aMT
aMT-egenskaper
Synonym: alfa-metyltryptamin
CAS-nummer: 299-26-3
Formel: C11H14N2
Molmassa: 174,247 g mol−1
Renhet: >98%
€34.95 – €499.95Prisintervall: €34.95 till €499.95
* Informationen på denna sida är en sammanfattning och är inte avsedd att täcka all tillgänglig information om detta läkemedel. Den täcker inte alla möjliga användningsområden, anvisningar, försiktighetsåtgärder, läkemedelsinteraktioner eller biverkningar och ersätter inte din vårdgivares expertis och bedömning.
AMT (Alpha-Methyltryptamine) – Scientific Product Description
General Information
Substance Name: Alfa-metyltryptamin (AMT)
Chemical Class: Tryptamine derivative
Status: Research chemical
Dosage: Varies (10-50mg for research purposes)
Form: Powder or pellets (depending on availability)
Farmakologiska egenskaper
AMT is a monoamine alkaloid with a unique mechanism of action that both:
Serotonergic (5-HT₂A agonism)
Dopaminergic (dopamine reuptake inhibition)
Exhibits noradrenergic effects
Potential Research Areas
1. Neuropsychological Examination
Influence on perceptual processing
Modulation of cognitive flexibility
Effects on creative thinking
2. Behavioral Science Studies
Social interaction patterns
Emotional processing mechanisms
Motivation and reward systems
3. Theoretical Applications
Possible antidepressant effects (preclinical study)
Impact on sleep architecture
Neuroplastic changes
Dosage & Protocol
Research dose range:
Låg dos: 10–20 mg
Genomsnittlig dos: 20–35 mg
Hög dos: 35–50 mg
Time lapse:
Onset of effects: 45-90 minutes
Peak performance: 3-5 hours
Total duration: 8-12 hours
Safety aspects
Biverkningar
Increased body temperature
Tachycardia
Mydriasis
Possible gastrointestinal discomfort
Contraindications
Combination with MAO inhibitors
Cardiovascular diseases
Psychiatric history
Laboratory analysis
Renhet: ≥97% (HPLC)
Stability: Store in a cool, dry place (<25°C)
Impurities: <0.5% (GC-MS analysis)
Rättslig ställning
Netherlands: Opium Act Schedule I
Belgium: Prohibited substance
EU: Under EU NPS legislation
Research protocols
Start low: 10mg initial test dose
Pharmaceutical monitoring: Blood pressure and temperature measurement
Intervals: Minimum 7 days between experiments
Important Warnings
❌ Ingen mänsklig konsumtion
❌ Do not combine with other psychoactives
❌ Avoid prolonged or frequent use
This product is intended solely for in vitro research och scientific study under controlled laboratory conditions.
1cP-LSD 150 MCG Art Blotters O-DSMT 50 mg pellets 1V-LSD 150 MCG Blotters 6-CL-ADBA
